J L Halperin Selected Research

Ischemic Stroke

7/2000

Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J L Halperin Research Topics

Disease

7	Stroke (Strokes) 08/2015 - 01/2000
6	Atrial Fibrillation 08/2015 - 01/2000
4	Hemorrhage 09/2015 - 08/2013
2	Thrombosis (Thrombus) 09/2015 - 05/2001
2	Myocardial Infarction 07/2015 - 03/2000
2	Heart Failure 07/2015 - 01/2000
1	Embolism (Embolus) 07/2015
1	Peripheral Arterial Disease 07/2015
1	Thromboembolism 08/2013
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2013
1	Venous Thromboembolism 08/2013
1	Ovarian Neoplasms (Ovarian Cancer) 07/2000
1	Brain Ischemia (Cerebral Ischemia) 07/2000
1	Ischemic Stroke 07/2000
1	Vascular Diseases (Vascular Disease) 03/2000
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2000

Drug/Important Bio-Agent (IBA)

6	Warfarin (Coumadin)FDA LinkGeneric 08/2015 - 01/2000
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2000 - 01/2000
3	AnticoagulantsIBA 09/2015 - 05/2001
3	RivaroxabanIBA 07/2015 - 08/2013
2	Factor Xa InhibitorsIBA 08/2015 - 07/2015
1	Antiphospholipid AntibodiesIBA 09/2015
1	fibrin fragment D (D-dimer)IBA 08/2015
1	darexabanIBA 08/2015
1	apixabanIBA 07/2015
1	edoxabanIBA 07/2015
1	Proteins (Proteins, Gene)FDA Link 07/2000
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2000
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2000

Therapy/Procedure

6	Therapeutics 08/2013 - 01/2000
1	Duration of Therapy 09/2015
1	Electric Countershock (Cardioversion) 05/2001
1	Secondary Prevention 03/2000